be a major factor of this trans-differentiation process, morphology are not known because of a lack of followup biopsies, it is very likely that ACE inhibitors it is possible that ANG II-mediated TGF-b synthesis contributes to the ultimate loss of functioning tubular attenuate tubulointerstitial fibrosis, and prevent, at least to some extent, the development of tubular epithelium.
Experimental studies provided convincing evidence atrophy. Whether AT receptor antagonists have similar effects is controversially discussed and the subject of that interference with the renin-angiotensin system (RAS ) by angiotensin-converting enzyme (ACE) ongoing studies [21] . Therefore, every patient with chronic renal disease, independent of blood pressure, inhibitors or AT 1 receptor antagonists reduces the development of tubulointerstitial fibrosis in various should be treated with an ACE inhibitor to slow the progression of chronic renal disease. animal models including chronic aminonucleoside nephrosis [12] , 5/6 nephrectomy [13] , unilateral ureteral obstruction [14] , chronic cyclosporin nephro-
